Function and expression of endothelin receptor subtypes in the kidneys of spontaneously hypertensive rats

Cardiovascular Research

Volumn 31, Issue 4, 1996, Pages 499-510

  Hocher, Berthold ^a,b,e   Rohmeiss, Peter ^c   Zart, Rüdiger ^b   Diekmann, Fritz ^a   Vogt, Volker ^c   Metz, Dieter ^b   Fakhury, Myriam ^a   Gretz, Norbert ^c   Bauer, Christian ^b   Koppenhagen, Klaus ^d   Neumayer, Hans H ^a   Distler, Armin ^d  

^a Univ Klin Char Humboldt Univ Z   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e Abt fur Nephrologie   (Germany)

Author keywords

endothelin receptor; endothelin receptor antagonist; hypertension; rat, kidney; rat, spontaneously hypertensive

Indexed keywords

BOSENTAN; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR AGONIST; ENDOTHELIN RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; GLOMERULUS FILTRATION RATE; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; AUTORADIOGRAPHY; BLOOD PRESSURE; BLOTTING, NORTHERN; GLOMERULAR FILTRATION RATE; HYPERTENSION; IN SITU HYBRIDIZATION; KIDNEY; KIDNEY GLOMERULUS; MALE; MUSCLE, SMOOTH, VASCULAR; PEPTIDES, CYCLIC; PROTEIN BINDING; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, ENDOTHELIN; RENAL CIRCULATION; RNA, MESSENGER; SULFONAMIDES; UP-REGULATION;

EID: 0029876577     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/0008-6363(95)00200-6     Document Type: Article

References (31)

1. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (Lond.) 1988;332:411-415.
2. Gross P, Renn C, Waldherr R, Seifen M, von Baehr R, Hocher B. Potential role of endothelin in the physiological and pathological regulation of kidney function. Endothelium 1993;1:71-83.
3. Lüscher TF, Seo BG, Bühler FR. Potential role of endothelin in hypertension. Controversy on endothelin in hypertension. Hypertension 1993;21:752-757.
4. Clozel M, Gray GA, Breu V, Löffler BM, Osterwalder R. The endothelin ETB receptor mediates both vasodilatation and vasoconstriction in vivo. Biochem Biophys Res Commun 1992;186:867-873.
5. Hirata Y, Emori T, Eguchi S, et al. Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. J Clin Invest 1993;91(4):1367-1373.
6. Moritoki H, Miyano H, Takeuchi S, Yamaguchi M, Hisayama T, Kondoh W. Endothelin-3-induced relaxation of rat thoracic aorta: a role for nitric oxide formation. Br J Pharmacol 1993;108(4):1125-1130.
7. Yokokawa K, Tahara H, Kohno M, et al. Hypertension associated with endothelin-secreting malignant hemangioendothelioma. Ann Intern Med 1991;114(3):213-215.
8. Paul M, Rettig R, Talsness CE, Zintz M, Yanagisawa M. Transgenic rats expressing the human endothelin-2 gene; a new model to study endothelin regulation in vivo. J Hypertension 1994;12:572 (Abstract).
9. Kurihara Y, Kurihara H, Suzuki H, et al. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature (Lond) 1004;368:703-710.
10. Evangelista, S, Maggi CA, Castellucci A. Effect of endothelin (ET)-1, ET-3 and ET-(16-21) on the isolated and perfused rat kidney from normotensive and spontaneously hypertensive rats. Jpn J Pharmacol 1992;59(2):239-241.
11. Tomobe Y, Miyauchi T, Saito A, et al. Effects of endothelin on the renal artery from spontaneously hypertensive and Wistar-Kyoto rats. Eur J Pharmacol 1988;152:373-374.
12. Ohno A, Naruse M, Kato S, et al. Endothelin-specific antibodies decrease blood pressure and increase glomerular filtration rate and renal plasma flow in spontaneously hypertensive rats. J Hypertens 1992;10:781-785.
13. Clozel M, Breu V, Gray GA, et al. Pharmacological, characterization of bosentan, a new potent orally active non-peptide endothelin receptor antagonist. J Pharmacol Exp Ther 1994;270:228-235.
14. Nambi P, Pullen M, Contino LC. Upregulation of renal endothelin receptors in rats with cyclosporine A-induced nephrotoxicity. Eur J Pharmacol 1990;187:113-116.
15. Hocher B, Rubens C, Hensen J, Gross P, Bauer C. Intracellular distribution of endothelin-1 receptors in rat liver cells. Biochem Biophys Res Commun 1992;184:498-503.
16. Hocher B, Rohmeiss P, Zart R, et al. Distribution of endothelin receptor subtypes in the rat kidney; renal and haemodynamic effects of the mixed (A/B) endothelin receptor antagonist bosentan. Eur J Clin Chem Clin Biochem 1995;33:463-472.
17. Sambrook J, Fritsch E, Maniatis T. 1989 Molecular Cloning. A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press, USA.
18. Lin HY, Kaji EH, Winkel GK, Ives HF, Lodish HF. Cloning and functional expression of a vascular smooth muscle endothelin 1 receptor. Proc Natl Acad Sci USA 1991;88(8):3185-3189.
19. Sakurai T, Yanagisawa M, Takuwa YM, et al. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 1990;348:732-735.
20. Hocher B, Abou-Rebyeh H, Plaum M, Fakhury M, Schiller S, Bauer C. Expression of the erb B oncogene in the Morris hepatoma 7777. Eur J Clin Chem Clin Biochem 1994;32:697-704.
21. Rohmeiss P, Photiadis J, Rohmeiss S, Unger T. Hemodynamic actions of intravenous endothelin in the rat:comparison with sodium nitroprusside and methoxamine. Am J Physiol 1990;258:H337-H346.
22. Wende P, Strauch M, Unger T, Gretz N, Rohmeiss P. Autoregulation of renal blood flow, glomerular filtration rate and plasma renin activity in spontaneously hypertensive rats and normotensive Wistar rats. Med Klin 1993;88(4):207-211.
23. Drost C. Vessel-diameter independent volume flow measurements using ultrasound. Proc San Diego Biomed Symp 1978;17:299-302.
24. Gretz N, Ecker-Tschimer KH, Kühnle HF, et al. Practicability of the inulin plasma single-shot clearance. Contr Nephrol 1990;81:220-228.
25. Kühnle HF, Dahl D, Schmidt FH. Fully enzymatic determination in small volume samples without deproteinization. Nephron 1992;62:104-107.
26. Bakris GL, Re RN Endothelin modulates angiotensin II-induced mitogenesis of human mesangial cells. Am J Physiol 1993;264(6 Pt 2):F937-F942.
27. Simonson MS, Herman WF. Protein kinase C and protein tyrosine kinase activity contribute to mitogenic signaling by endothelin-1. Cross-talk between G protein-coupled receptors and pp60c-src. J Biol Chem 1993;268(13):9347-9357.
28. 125I-endothelin-1 in rat kidney and lung examined by electron microscopic autoradioautography. Anat Embryol (Berl) 1992;185(1):87-96.
29. Gellai MR, DeWolf R, Pullen M, Nambi P. Distribution and functional role of renal ET receptors subtypes in normotensive and hypertensive rats. Kidney Int 1994;46:1287-1294.
30. Bazil MK, Lappe RW, Webb RL, Pharmacologic characterization of an endothelin A (ETA) receptor antagonist in conscious rats. J Cardiovasc Pharmacol 1992;20:940-948.
31. Li JS, Schiffrin EL. Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist. Hypertension 1995;25:495-500.